Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study

CompletedOBSERVATIONAL
Enrollment

1,102

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

October 31, 2011

Conditions
StrokeTransient Ischemic Attack
Interventions
PROCEDURE

Sampling of 15ml blood

On admission, 2 x 7.5ml blood tubes will be drawn during the first routine blood sampling

PROCEDURE

Blood-Sampling

On day 1 after intra-arterial thrombolysis, 2 x 7.5ml blood tubes on the following routine blood-sampling will be drawn.

Trial Locations (4)

3010

University Clinic for Neurology, Bern University Hospital, Bern

4031

Neurologische Klinik, Universitätsspital Basel, Basel

Unknown

Abteilung für Neurologie Charité - Campus Benjamin Franklin, Berlin

Goethe University, Frankfurt am Main

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Basel

OTHER

collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Goethe University

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT00878813 - Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk Study | Biotech Hunter | Biotech Hunter